Dr. Todd Cooper, Oncology section chief and director of Seattle Children’s Pediatric Leukemia/Lymphoma Program, as well as principal investigator in the Ben Towne Center for Childhood Cancer Research, has been appointed to chair the Children’s Oncology Group (COG) Myeloid Committee, effective May 1.

The COG is the largest consortium of pediatric hospitals providing oncology services in the world. It unites more than 10,000 cancer experts at about 250 hospitals across North America, Australia and New Zealand.

Cooper, who is also a professor of pediatrics at the University of Washington School of Medicine and the Evans Family Endowed Chair in Pediatric Cancer, will be responsible for setting COG’s vision and priorities for clinical/translational research and clinical care for pediatric and young adult malignancies, including acute myeloid leukemia (AML), acute myeloid leukemia of Down syndrome (AML-DS), chronic myelogenous leukemia (CML) and other myeloproliferative neoplasms.

He will work with experts throughout COG institutions to develop and conduct blood cancer clinical trials and protocols, as well as working with other international AML consortia to ensure COG’s clinical/translational priorities are synchronized and complementary. Read full post »